UpdateBot at 23:24, 29 March 2022

2022-03-29T23:24:40Z

New page

{{short description|Subsidiary of National Dairy Development Board}}
{{Use dmy dates|date=September 2018}}
{{Use Indian English|date=September 2018}}
{{Infobox company
| name = Indian Immunologicals Limited..
| image = IIL India logo.jpg
| type = [[Subsidiary]] of [[National Dairy Development Board]]
| industry = Biotechnology
| hq_location = Hyderabad
| hq_location_country = India
| key_people = Dr. K. Anand Kumar (Managing Director)
| website = https://www.indimmune.com
}}
'''Indian Immunologicals Limited''' or '''IIL''' is a [[subsidiary]] of [[National Dairy Development Board]]. It is based in [[Hyderabad]], [[Telangana]], [[India]].<ref>{{Cite web|title=Two Central Government PSUs, namely, Indian Immunologicals Ltd (IIL) and BIBCOL have entered into a technology transfer agreement with Bharat Biotech.|url=https://pib.gov.in/PressReleaseIframePage.aspx?PRID=1718332|last=|first=|date=|website=Press Information Bureau|url-status=live|archive-url=|archive-date=|access-date=}}</ref> IIL is registered in India as a Public Limited Company under the Companies Act, 1956 ([[Ministry of Corporate Affairs|Ministry Of Corporate Affairs]] - MCA Services),<ref>{{Cite web |title=Indian Immunologicals Limited Information - Indian Immunologicals Limited Company Profile, Indian Immunologicals Limited News on The Economic Times |url=https://economictimes.indiatimes.com/company/ |access-date=2022-03-24 |website=The Economic Times |language=en}}</ref> It was established in 1982 by the [[National Dairy Development Board]].<ref>{{Cite web|title=Indian Immunologicals eyes oral vaccine for cervical cancer|url=https://www.thehindubusinessline.com/todays-paper/tp-corporate/Indian-Immunologicals-eyes-oral-vaccine-for-cervical-cancer/article20039264.ece|last=|first=|date=|website=The Hindu BusinessLine|url-status=live|archive-url=|archive-date=|access-date=29 June 2010}}</ref><ref>{{Cite web|title=Indian Immunologicals Limited|url=http://www.indimmune.com/news.html|last=|first=|date=|website=Internet Archive|url-status=live|archive-url=https://web.archive.org/web/20120415123710/http://www.indimmune.com/news.html|archive-date=15 April 2012|access-date=}}</ref>

It is noted for developing veterinary and human vaccines for [[foot-and-mouth disease]], [[rabies]], bacterial vaccines, canine vaccines, [[hepatitis]], [[measles]], [[MMR vaccine|MMR]] and [[DPT vaccine|DPT]].

IIL is a major supplier of DPT, TT and Hepatitis B vaccines to India's large Universal Immunization Programme.<ref>{{Cite news|title=Indian Immunologicals to launch 4 vaccines in a year|url=https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/indian-immunologicals-to-launch-4-vaccines-in-a-year/articleshow/5990824.cms|last=|first=|date=|website=The Economic Times|url-status=live|archive-url=|archive-date=|access-date=30 May 2010}}</ref><ref>{{Cite web|title=Indian manufacturers account for 60% of vaccine supplies made to UNICEF|url=https://www.biospectrumasia.com/opinion/37/9356/indian-manufacturers-account-for-60-of-vaccine-supplies-made-to-unicef.html|last=|first=|date=|website=BioSpectrum|url-status=live|archive-url=|archive-date=|access-date=22 August 2017}}</ref> IIL has three vaccine manufacturing facilities in India. The Gachibowli-Hyderabad facility is engaged in the production of vaccines, while the Karakapatla-Hyderabad facility produces animal health formulations and human vaccines. IIL's facility in Ooty exclusively produces human anti-rabies vaccine, “Abhayrab”. Pristine Biologicals Ltd is IIL's subsidiary in New Zealand and is involved in the production of serum used in the manufacture of vaccines.<ref>{{Cite web|last=|first=|date=|title=IIL to invest rs 75 crore to expand Its karkapatla plant in telangana|url=http://www.uniindia.com/iil-to-invest-rs-75-crore-to-expand-its-karkapatla-plant-in-telangana/business-economy/news/1641867.html|url-status=live|archive-url=|archive-date=|access-date=|website=}}</ref>

== Animal Health ==
IIL manufactures animal health vaccines and formulations. IIL is the third largest animal health player in the Indian market and the market leader in veterinary biologicals in India. IIL operates one plant that is WHO-GMP and ISO-9001, 14001, 18001 and 27001 certified. IIL also introduced the world's first vaccine against Porcine Cysticercosis –Cysvax. IIL is the only producer of companion animal vaccines in India.<ref>{{Cite web|title="Indian manufacturers account for 60% of vaccine supplies made to UNICEF"|url=https://www.biospectrumasia.com/opinion/37/9356/indian-manufacturers-account-for-60-of-vaccine-supplies-made-to-unicef.html|access-date=2020-11-24|website=www.biospectrumasia.com|language=en}}</ref>

== Human Health ==

IIL operates a manufacturing facility in [[Ooty]] to manufacture the Vero cell culture rabies vaccine for use in human beings. This plant was set up in 1998 at the specific request of the Government of India in order to phase out use of the older and unsafe sheep brain vaccine (also termed nerve tissue vaccine – NTV) with the modern tissue culture vaccine.

The plant, which commenced commercial production in phases from September 2006, meets a large part of the requirements of the Universal Immunization Programme of the Ministry of Health, Govt of India.<ref>{{Cite web|title=Human Biologicals Institute launches Eco Friendly Pack for its Anti Rabies Vaccine 'Abhayrab'|url=https://health.economictimes.indiatimes.com/news/pharma/human-biologicals-institute-launches-eco-friendly-pack-for-its-anti-rabies-vaccine-abhayrab/73156662|last=|first=|date=|website=Economic Times HealthWorld.com|url-status=live|archive-url=|archive-date=|access-date=8 January 2020}}</ref>

== Human Biologicals Institute ==
IIL established Human Biologicals Institute (HBI) in 1999 to manufacture modern Tissue Culture Anti Rabies Vaccine (TCARV) for human use at Ooty, Tamil Nadu. <ref>{{Cite web|last=|first=|date=|title=immunology|url=https://www.nddb.coop/services/rdbiotech/immunology|url-status=live|archive-url=|archive-date=|access-date=|website=}}</ref>

== International Business ==
IIL exports its products to more than 50 countries across the world with a customer focus in Middle East, Asia, Africa, CISR countries and expanding in Central and Latin America.<ref>{{Cite web|title=International Business {{!}} Indian Immunologicals Ltd (IIL)|url=https://www.indimmune.com/business-unit/international-business|access-date=2020-11-24|website=IIL|language=en-gb}}</ref>

== Coronavirus Vaccine Development ==
Immunologicals Limited (IIL) is developing a vaccine for coronavirus in a cross-continental collaboration. It is leading the cross-continental research collaboration in association with the Griffith University of Australia to develop 'live attenuated SARS-CoV-2 Vaccine or COVID-19 vaccine' using the latest codon de-optimization technology.<ref>{{Cite web|title=Indian Immunologicals Ltd to develop COVID-19 vaccine in association with Griffith University of Australia|url=https://www.timesnownews.com/health/article/indian-immunologicals-ltd-to-develop-covid-19-vaccine-in-association-with-griffith-university-of-australia/596045|access-date=2020-11-24|website=www.timesnownews.com|language=en}}</ref>

==See also==
*[[Genome Valley]]

==References==
{{reflist}}

{{authority control}}

[[Category:Research institutes in Hyderabad, India]]
[[Category:Health care companies of India]]
[[Category:Biotechnology companies of India]]
[[Category:1983 establishments in Andhra Pradesh]]
[[Category:Pharmaceutical companies established in 1983]]
[[Category:Government-owned companies of India]]
[[Category:Biotechnology companies established in 1983]]

Indian Immunologicals Limited - Revision history

UpdateBot at 23:24, 29 March 2022